solifenacin succinate

Ajanta Pharma USA Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 22, 2021
Approval ID: 9558ed7a-e942-4261-8aea-6033352f79b8
Products: 2 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SOLIFENACIN SUCCINATE TABLETS safely and effectively. See full prescribing information for SOLIFENACIN SUCCINATE TABLETS. SOLIFENACIN SUCCINATE tablets, for oral use Initial U.S. Approval: 2004

Quick Stats

Total Products2

Labelers2

Label Sections33

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.